Another case report study referred about the efficacy of ACT using CD4 T cells directed against the mutated ERBB2 protein expressed by the tumor cells in a patient with a metastatic epithelial cancer, mediating a successful tumor regression [118]. Here, CD4 is linked to neoplasm.